期刊文献+

新疆乌鲁木齐地区维吾尔族与汉族难治性高血压相关危险因素 被引量:4

Risk factors for resistant hypertension in the Uygur and Hans in the areas of Wulumuqi Xinjiang
原文传递
导出
摘要 目的探讨维吾尔族与汉族(维汉)难治性高血压(RH)相关危险因素的异同。方法收集2003-05-2010-02住院的原发性高血压患者1367例,其中RH673例,非RH694例,汉族967例,维吾尔族400例。对维汉两民族患者的性别、年龄、高血压病程、吸烟史、高血压家族史、肥胖、血脂异常、总胆固醇、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油、糖尿病、糖耐量异常(IGT)及慢性肾脏病(CKD)等相关危险因素,分别进行单因素及多因素logistic回归分析。结果汉族RH组与非RH组相比,IGT比例较低(P<0.05),年龄较大、高血压病程较长、总胆固醇水平较高(均P<0.05),糖尿病患病率高、CKD比例高、治疗不当比例高及血脂异常的比例高(均P<0.05);维吾尔族RH组与非RH组相比,高血压家族史及IGT的比例较低(均P<0.05),年龄较大、高血压病程较长(均P<0.05),糖尿病患病率高、CKD比例高及治疗不当的比例高(均P<0.05)。经logistic回归分析结果显示:糖尿病(OR=13.840,P<0.01)、CKD(OR=9.369,P<0.01)及高血压病程(OR=1.063,P<0.01)与汉族RH独立相关;糖尿病(OR=11.135,P<0.01)、CKD(OR=8.959,P<0.01)及高血压病程(OR=1.052,P=0.012)与维吾尔族RH独立相关。结论高血压病程、糖尿病及CKD是维汉共同的独立危险因素。 Objective To investigate the similarities and differences of the risk factors for resistant hypertension(RH)in the Uygur and hans.Methods One thousand and three hundred and sixty seven essential hypertensive inpatients were enrolled between May.2003 and Feb.2010.Among patients,673 RH,694 non-RH;967 Hans and 400 Uygur.The clinical data of patients were collected,including gender,age,course of disease,smoking history,family histories of hypertension,obesity,blood lipid abnormality,total cholesterol,high-density lipoprotein-cholesterol(HDL-C),low density lipoprotein-cholesterol(LDL-C),triglyceride,diabetes mellitus,impaired glucose tolerance(IGT),chronic kidney diseases(CKD).The univariate and multivariate logistic regressions were performed to analyze the risk factors of the Uygur and hans RH.Results Compared with non-RH group,hans patients with RH group presented lower prevalence of IGT(P 0.05),higher prevalence in elder patients,longer course of disease,higher total cholesterol herd,prevalence of diabetes,CKD,improper treatments and blood lipid abnormality(all P 0.05);Compared with non-RH group,Uygur patients with RH group presented lower prevalence of family history of hypertension and IGT(all P 0.05),higher prevalence in elder patients,longer course of disease,prevalence of diabetes,CKD and improper treatment(all P 0.05).Logistic regression analysis showed that hans RH was associated with diabetes mellitus(OR =13.840,P 0.01),CKD(OR =9.369,P 0.01)and course of disease(OR =1.063,P 0.01);Uygur RH was also associated with diabetes mellitus(OR =11.135,P 0.01),CKD(OR = 8.959,P 0.01)and course of disease(OR =1.052,P =0.012).Conclusion CKD,diabetes mellitus,course of disease were independent risk factors for both the Uygur and Hans RH.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2011年第2期159-162,共4页 Chinese Journal of Hypertension
关键词 维吾尔族 汉族 危险因素 难治性高血压 Uygur Hans Risk factor Resistant hypertension
  • 相关文献

参考文献7

  • 1Yamori Y, Nara Y. Nutritional factors for hypertension and major cardiovascular disease: International cooperative studies for dietary prevention[J]. DMW Jpn,1994,16(ll):1825-1841.
  • 2Wu Yingkai, Lu Changqing, Gao Runquan, et al. Nation-Wide hypertension screening in China during 1979 1980[J]. Chin Med J,1982,95(1) :101-108.
  • 3Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American heart professional education committee of the council for high blood pressure researeh[J]. Hypertension, 2008, 51 (6) : 1403-1419.
  • 4纪宝华.顽固性高血压治疗对策[J].中华心血管病杂志,2003,31(5):395-397. 被引量:55
  • 5Garg J P, Elliott W J, Folker A, et al. Resistant hypertension revisited: a eomparison of two university-based eohorts[J]. Am J Hypertens,2005,18(5) : 619-626.
  • 6翁新植 等译.WHO关于吸烟情况调查方法标准化建议(节译).心肺血管学报,1984,3(1):21-21.
  • 7Cushman WC, Ford CE, Cutler JA. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J]. J Clin Hypertens,2002,4(2) :393-404.

二级参考文献13

  • 1The sixth report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure. Arch Intern Med,1997,157: 2413-2446.
  • 2Gifford RW Jr. An Algorithm for the management of resistant hypertension. Hypertension, 1988.11 ( 3 Pt 2) : II101-II105.
  • 3Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens, 2001,14 : 1263-1269.
  • 4Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenypropanolamine ( PPA ). A review of 142 case reports. Am J Med. 1990.89:195-198.
  • 5Black HR. Management of patients with refractory hypertension. In:Izzo JL, Black,ed. Hypertension Primer. Second Edition. Am Heart Association Chapter, 1999. 123,354-357.
  • 6Morimoto S, Sasaki S. Lopemmide therapy in a patient with diarrhea and resistant hypertension. Am J Hypertens,2000, 13 : 431-432.
  • 7Kaplan NM. Anxiety-induced hypertension. A common cause of symptoms in patients with hypertension. Arch Intern Med, 1997,157: 945-948.
  • 8Klassen PS. Diagnosis and management of renovaseular hypertension. Cardiol Rev,2000,8 : 17 -30.
  • 9Rayner BL, Opie LH, Davidson TS, et al. The aldosteronism/renin ratio as screening test for primary aldosteronism. SAMH, 2000,90:394-400.
  • 10Gallay BJ, Ahmad S, Xu L, et al. Screening for primary aldosteronism ABR without discontinuing hypertensive medications.Am J Kidney Dis, 2001,37:699-705.

共引文献56

同被引文献44

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部